Tivozanib: ¿hace falta un nuevo Tki en 1L de RCC?

Previous Page

Next Page

Page Background

Taguchi E, et al. Cancer Sci 2008

Activity of KRN951 (Tivozanib):

antitumor activity

and tumor vessel normalization in a rat peritoneal disseminated tumor model